Single use or disposable bioreactors come with disposable bags that can be replaced. These are different from the reactors that come with culture vessels. The lining of these reactors could be made out of plastic along with more permanent structures. They are widely used for mammalian tissue culture and are expected to replace the conventional bioreactors. Strong rise in the demand from different parts of the world and investments from small and medium businesses are expected to create potential growth opportunities for the global single use bioreactor market in the years to come. Advancing technologies and rising demand from the developing countries is also expected to provide potential traction to this market in the years to come.
Segmentation in Disposable Bioreactors Market
Researchers segment the single use bioreactors market on the basis of the types of molecular types, types of cells, technologies and their demand from various end-users and geographic regions. Based on molecular types, the market is segmented into vaccines, monoclonal antibodies, stem cells, recombinant proteins, gene therapy and others including infernos, growth factors, RNA interference and antisense. The types of technologies in the market include single use bubble-column bioreactors, stirred SUBs, wave-induced motion SUBs, and others such as hybrid and vertically perforated SUBs. The types of cells include yeast, bacteria, mammalian cells, plant cells and insect cells. Major end-users in the market include research and development departments of various research institutes, biopharmaceutical manufacturers, CROs, and biopharmaceutical manufacturers.
Major Drivers, Restraints & Market Forecasts
According to the experts, the single use bioreactor market is steadily driven by several vital elements. One of them includes strong business opportunities for the small and medium businesses. Strong return on investments is driving many SMBs towards this market, which is considered to be a vital sign for the overall market. Positive impact on the environment and easy cultivation of algae and other marine organisms are also some of the major driving factors for the growth of this market. Major restraining factors for the market include issues concerning extractables and leachables, difficulty meeting the GMP standards and strong regulatory concerns. Apart from that, rising need for improved and flexible bioreactors and sensors are also expected to restraint the growth of this market. However, strong prospects for the biologics market are expected to provide vital growth opportunities in future.
As per the latest research reports, the single use bioreactor market is estimated to be worth $470.9 million by the end of the year 2019. According to the researchers, the market is estimated to grow at an impressive CAGR of over 18% from the forecasting period of 2014 to 2019. During the forecasting period, the mammalian cells segment is expected to dominate the global market. Based on geographic regions, the market is estimated to be dominated by Europe, which is followed by North America.
